Skip to main content
. 2016 Mar 21;2016(3):CD009645. doi: 10.1002/14651858.CD009645.pub3

Lindenberg 2010.

Methods Study design: sham‐controlled double‐blinded randomised trial
Dropouts: not stated
Adverse effects: none
Deaths: not stated, likely none
ITT: not stated
Participants Country: USA
Number of participants: 20 chronic stroke participants
Age: (mean ± SD) 55.8 ± 12.9 years
Gender: 5 female (25%)
Type of stroke: first and only ischaemic stroke
Time poststroke: (mean ± SD) 40.3 ± 23.4 months
Severity: UE‐FM Score (mean ± SD) 39.8 ± 11.5
Inclusion criteria: ischaemic stroke in the territory of the medial cerebral artery at least 5 months before enrolment; no previous or subsequent strokes; MRC strength grade of 3/5 in extensor muscles of the lesioned upper extremity in the acute phase with at least 15 degrees of active wrist dorsiflexion at enrolment
Exclusion criteria: additional neurological or psychiatric disorders; concurrent use of CNS‐affecting drugs
Interventions Number of arms: 2, each participant underwent 5 consecutive sessions of physical therapy/occupational therapy and 1 of the following interventions
  1. Dual‐tDCS: A‐tDCS over M1 of the lesioned hemisphere + C‐tDCS over M1 of the non‐lesioned hemisphere (1.5 mA each, for 30 minutes)

  2. Sham tDCS (for 30 minutes)

Outcomes Primary outcome measure: UE‐FM scores (0 to 66, with higher scores reflecting better motor performance)
Secondary outcome measure: WMFT (with lower scores indicating better motor performance)
Time point of measurement: at baseline and at 3 and 7 days after the last intervention session
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "Patients were randomly assigned to one of two groups ... using a block randomisation with 3 strata of impairment"
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) 
 Subjective outcome measures Low risk There were no subjective outcome measures
Blinding of participants and personnel (performance bias) 
 Objective outcome measures Low risk Participants and personnel were blinded
Blinding of outcome assessment (detection bias) 
 Subjective outcome measures Low risk There were no subjective outcome measures
Blinding of outcome assessment (detection bias) 
 Objective outcome measures Low risk Quote: "Each patient underwent motor impairment assessments and MRI at baseline and after the intervention, conducted by trained individuals who were blinded to the type of intervention the patients received"
Incomplete outcome data (attrition bias) 
 Subjective outcome measures Low risk There were no subjective outcome measures
Incomplete outcome data (attrition bias) 
 Objective outcome measures Unclear risk All randomised participants apparently completed the study. No treatment withdrawals, no losses to follow‐up, no trial group changes and no major adverse events were stated
Selective reporting (reporting bias) Unclear risk All outcomes stated in the methods section were reported